Metformin use and improved response to therapy in rectal cancer-Reference-Cited by-同舟云学术

Metformin use and improved response to therapy in rectal cancer

Published:2013-01-21 Issue:1 Volume:2 Page:99-107
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Skinner Heath D.¹,Crane Christopher H.¹,Garrett Christopher R.²,Eng Cathy²,Chang George J.³,Skibber John M.³,Rodriguez‐Bigas Miguel A.³,Kelly Patrick¹,Sandulache Vlad C.⁴⁵,Delclos Marc E.¹,Krishnan Sunil¹,Das Prajnan¹

Affiliation:

1. Department of Radiation Oncology The University of Texas MD Anderson Cancer Center Houston Texas 77030

2. Department of Gastrointestinal Medical Oncology The University of Texas MD Anderson Cancer Center Houston Texas 77030

3. Department of Surgical Oncology The University of Texas MD Anderson Cancer Center Houston Texas 77030

4. Department of Head and Neck Surgery The University of Texas MD Anderson Cancer Center Houston Texas 77030

5. Bobby R. Alford Department of Otolaryngology‐Head and Neck Surgery Baylor College of Medicine Houston Texas 77030

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.54

Reference35 articles.

1. Cancer Statistics, 2010

2. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data

3. Complete Pathologic Response after Combined Modality Treatment for Rectal Cancer and Long-Term Survival: A Meta-Analysis

4. Preoperative Concurrent Chemoradiotherapy for Locally Advanced Rectal Cancer: Treatment Outcomes and Analysis of Prognostic Factors

5. Neoadjuvant Treatment Response As an Early Response Indicator for Patients With Rectal Cancer

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of renin angiotensin system inhibitors and metformin in Glioblastoma Therapy: a review;Cancer Chemotherapy and Pharmacology;2024-06-25

2. Navigating Molecular Pathways: An Update on Drugs in Colorectal Cancer Treatment;Current Topics in Medicinal Chemistry;2023-12

3. Metformin Does not Affect Outcomes in Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Therapy and Resection;The American Surgeon™;2023-11-16

4. Phase I / II trial of metformin as a chemo-radiosensitizer in a head and neck cancer patient population;Oral Oncology;2023-10

5. Metformin is a metabolic modulator and radiosensitiser in rectal cancer;Frontiers in Oncology;2023-08-03